Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6530
Gene Symbol: SLC6A2
SLC6A2
0.010 Biomarker phenotype BEFREE These findings suggest that combining strong NET and weak DAT inhibition could lead to the development of a highly effective cognitive enhancer that lacks the potential for addiction. 31580915 2020
Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
0.010 Biomarker phenotype BEFREE We interrogated the well-described mechanism of MEK/ERK pathway inhibitor addiction in solid tumors and found it does not apply to ALCL. 31804622 2020
Entrez Id: 9603
Gene Symbol: NFE2L3
NFE2L3
0.010 Biomarker phenotype BEFREE Our group has recently discovered a new addiction to the NRF2-related factor NRF3 (NFE2L3) in cancer. 31742837 2020
Entrez Id: 238
Gene Symbol: ALK
ALK
0.010 Biomarker phenotype BEFREE Instead, phosphoproteomics and confirmatory functional studies revealed that the STAT1 overactivation is the key mechanism of ALK-TKI addiction in ALCL. 31804622 2020
Entrez Id: 6772
Gene Symbol: STAT1
STAT1
0.010 Biomarker phenotype BEFREE Instead, phosphoproteomics and confirmatory functional studies revealed that the STAT1 overactivation is the key mechanism of ALK-TKI addiction in ALCL. 31804622 2020
Entrez Id: 2048
Gene Symbol: EPHB2
EPHB2
0.010 Biomarker phenotype BEFREE We interrogated the well-described mechanism of MEK/ERK pathway inhibitor addiction in solid tumors and found it does not apply to ALCL. 31804622 2020
Entrez Id: 6319
Gene Symbol: SCD
SCD
0.010 Biomarker phenotype BEFREE In addition, opioid management for SCD is dogged by stigma and concerns regarding addiction. 31593753 2020
Entrez Id: 1055
Gene Symbol: CECR
CECR
0.010 Biomarker phenotype BEFREE Pearson correlation analysis results showed: CES-D was significantly (<i>P</i> < 0.01) and positively correlated with IAII(<i>r</i> = 0.640); CES-D was negatively correlated with SRSS (<i>r</i> = -0.364) and CD-RISC (<i>r</i> = -0.393); The mediating effect results showed that internet addiction partially mediated the association between social support and depressive symptoms (64.9% proportion mediated). 31630539 2020
Entrez Id: 5141
Gene Symbol: PDE4A
PDE4A
0.010 AlteredExpression phenotype BEFREE These results indicate that GXE enhances sensitivity to repeated cocaine exposure via an increase in PDE4 activity in NAc D2-recptor-expressing neurons, leading to the development of cocaine addictive behaviors. 30831136 2020
Entrez Id: 3062
Gene Symbol: HCRTR2
HCRTR2
0.010 Biomarker phenotype BEFREE In this regard, studies on both orexin-1 receptors (OX1Rs) and orexin-2 receptors (OX2Rs) have shown some positive results, suggesting that single orexin receptor antagonists (SORAs) and dual orexin receptor antagonists (DORAs) may hold promising efficacy in the treatment of addiction compared to the currently used methods. 30476469 2020
Entrez Id: 131450
Gene Symbol: CD200R1
CD200R1
0.010 Biomarker phenotype BEFREE In this regard, studies on both orexin-1 receptors (OX1Rs) and orexin-2 receptors (OX2Rs) have shown some positive results, suggesting that single orexin receptor antagonists (SORAs) and dual orexin receptor antagonists (DORAs) may hold promising efficacy in the treatment of addiction compared to the currently used methods. 30476469 2020
Entrez Id: 3061
Gene Symbol: HCRTR1
HCRTR1
0.010 Biomarker phenotype BEFREE In this regard, studies on both orexin-1 receptors (OX1Rs) and orexin-2 receptors (OX2Rs) have shown some positive results, suggesting that single orexin receptor antagonists (SORAs) and dual orexin receptor antagonists (DORAs) may hold promising efficacy in the treatment of addiction compared to the currently used methods. 30476469 2020
Entrez Id: 3765
Gene Symbol: KCNJ9
KCNJ9
0.010 Biomarker phenotype BEFREE Together, these data show that behavioral sensitivity to cocaine in mice is inversely proportional to the strength of GIRK channel activity in VTA DA neurons and suggest that direct activators of the unique VTA DA neuron GIRK channel subtype (GIRK2/GIRK3 heteromer) could represent a promising therapeutic target for treatment of addiction.<b>SIGNIFICANCE STATEMENT</b> Inhibitory G protein signaling in dopamine (DA) neurons, including that mediated by G protein-gated inwardly rectifying K<sup>+</sup> (GIRK) channels, has been implicated in behavioral sensitivity to cocaine. 30837265 2019
Entrez Id: 284
Gene Symbol: ANGPT1
ANGPT1
0.010 GeneticVariation phenotype BEFREE After stimulation of VEGF or bradykinin, the addiction to equimolar amounts of wtANGPT1 and ANGPT1 p.A119S clearly reduced the expression of VE-cadherin on the endothelial cell surface (31% and 24% respectively). 30689269 2019
Entrez Id: 4820
Gene Symbol: NKTR
NKTR
0.010 GeneticVariation phenotype BEFREE The MADDERS® system discerns potentially abuse-related events and identified low rates of withdrawal and a low risk of abuse potential, diversion or addiction associated with NKTR-181 in phase 3 trials. 30932719 2019
Entrez Id: 526
Gene Symbol: ATP6V1B2
ATP6V1B2
0.010 GeneticVariation phenotype BEFREE The treatment of primary FL B cells with inhibitors of autophagy uncovered an addiction for survival for FL B cells harboring ATP6V1B2 mutations. 30720463 2019
Entrez Id: 706
Gene Symbol: TSPO
TSPO
0.010 Biomarker phenotype BEFREE With an emphasis on neuroimaging techniques, this review examines human studies of addiction using positron emission tomography to identify binding of translocator protein (TSPO), which is upregulated in reactive glial cells and activated microglia during pathological states. 30695700 2019
Entrez Id: 3075
Gene Symbol: CFH
CFH
0.010 Biomarker phenotype BEFREE We aimed to elucidate the involvement of CFH and C1q in the mechanism of METH addiction. 30731099 2019
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.010 Biomarker phenotype BEFREE Nonsteroidal anti-inflammatory drugs (NSAIDs), selective COX-2 inhibitors and opioid drugs can temporarily reduce osteoporotic pain but have relevant side effects, such as addiction, tolerability and safety. 31294469 2019
Entrez Id: 56899
Gene Symbol: ANKS1B
ANKS1B
0.010 AlteredExpression phenotype BEFREE Overexpression of anks1b gene in the ventral tegmental area decreased addiction vulnerability for heroin and methamphetamine in self-administration rat models. 31462767 2019
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 Biomarker phenotype BEFREE Maximally-assisted therapy (MAT) is an interdisciplinary care intervention that includes ART dispensation to support individuals with a history of addiction and homelessness. 30269233 2019
Entrez Id: 1843
Gene Symbol: DUSP1
DUSP1
0.010 Biomarker phenotype BEFREE RNAi-mediated knock-down and pharmacological inhibition of DUSP1, involved in p38/JNK deactivation, in HEL cells reveals growth addiction to DUSP1, consistent with enhanced DNA damage response and apoptosis in DUSP1-inhibited parental JAK2V617F<sup>+</sup> cells, but not in CRISPR-modified JAK2 wild-type cells. 30967632 2019
Entrez Id: 6510
Gene Symbol: SLC1A5
SLC1A5
0.010 AlteredExpression phenotype BEFREE TNBC cells display addictions to glutamine in culture, and the levels of the glutamine transporter, alanine-serine-cysteine transporter 2 (ASCT2), are elevated in many types of cancer. 31403158 2019
Entrez Id: 79827
Gene Symbol: CLMP
CLMP
0.010 Biomarker phenotype BEFREE ASAM's Standards of Care for the Addiction Specialist established appropriate care for the treatment of substance use disorders. 29601307 2019
Entrez Id: 3643
Gene Symbol: INSR
INSR
0.010 GeneticVariation phenotype BEFREE Across multiple samples (n = 4502), the biologically informed, mesocorticolimbic or hippocampal specific insulin receptor polygenic scores were calculated, and their ability to predict impulsivity, risk for addiction, cognitive performance and presence of Alzheimer's disease was investigated. 30922963 2019